Biomarkers of radiographic progression in psoriatic arthritis: A report from the GRAPPA 2011 annual meeting

Journal of Rheumatology

Volumn 39, Issue 11, 2012, Pages 2189-2192

  Fitzgerald, Oliver ^a   Ritchlin, Christopher T ^b   Mease, Philip J ^c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Biomarkers; Psoriatic arthritis; Radiographic damage

Indexed keywords

ADALIMUMAB; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

BONE EROSION; BONE MARROW EDEMA; CONFERENCE PAPER; DACTYLITIS; DISEASE COURSE; JOINT DESTRUCTION; JOINT RADIOGRAPHY; JOINT SWELLING; MICRO-COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPHYTE; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; ITALY; OSTEOGENESIS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84868338841     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120820     Document Type: Conference Paper

References (11)

1. Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg Jd, kremer JM, et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large US disease registry. J Rheumatol 2010;37:2566-72.
2. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience. Rheumatology 2003;42:1460-8.
3. Finzel S, Englbrecht M, Engelke K, Stach C, Schett G. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum dis 2011;70:122-7.
4. Bond SJ, Farewell VT, Schentag CT, Gladman dd. Predictors for radiological damage in psoriatic arthritis: Results from a single centre. Ann Rheum dis 2007;66:370-6.
5. Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: A marker for disease severity? Ann Rheum Dis 2005;64:188-90.
6. Gladman DD, Mease PJ, Choy EH, Ritchlin CT, Perdok RJ, Sasso EH. Risk factors for radiographic progression in psoriatic arthritis: Subanalysis of the randomized controlled trial ADEPT. Arthritis Res Ther 2010;12:R113.
7. Mullan Rh, Matthews C, Bresnihan B, FitzGerald O, King L, Poole AR, et al. Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy. Arthritis Rheum 2007; 56:2919-28.
8. Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, et al. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum dis 2008;67:296-301.
9. Dalbeth N, Pool B, Smith T, Callon KE, Lobo M, Taylor WJ, et al. Circulating mediators of bone remodeling in psoriatic arthritis: Implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther 2010;12:R164.
10. Ng CT, Gibbs A, Murray B, Brady JJ, Bresnihan B, Veale DJ, et al. Bone biomarkers and bone density measurements in patients with inflammatory arthritis prior to and following anti-TNF therapy [abstract]. Arthritis Rheum 2008;58 Suppl:S587.
11. Wassenberg S, Fischer-kahle v, herborn G, Rau R. A method to score radiographic change in psoriatic arthritis. z Rheumatol 2001;60:156-66.